Results 171 to 180 of about 388,394 (322)
Romiplostim use in pregnant women with immune thrombocytopenia
American Journal of Hematology, Volume 98, Issue 1, Page 31-40, January 2023., 2023 Abstract Treatment for immune thrombocytopenia (ITP) in pregnancy is hampered by the lack of fetal safety evidence of maternally‐administered medications. The Pregnancy Surveillance Program (PSP) collected patient information from 2017–2020 for pregnancy, birth outcomes, and adverse events (AEs) for 186 women exposed to romiplostim from 20 days before ...
James B. Bussel +7 more
wiley +1 more source
Alzheimer's disease comorbidity in normal pressure hydrocephalus: prevalence and shunt response [PDF]
, 2000 James Golomb
openalex +1 more source
Sex differences in lymphoma incidence and mortality by subtype: A population‐based study
American Journal of Hematology, Volume 98, Issue 1, Page 23-30, January 2023., 2023 A higher incidence and a trend toward higher mortality in men for most lymphoma subtypes is seen in this Swedish population‐based cohort study on adults (age 18‐99) diagnosed with lymphoma 2000‐2019. Male‐to‐female incidence rate ratio (IRR) by male‐to‐female excess mortality ratio (EMR), both adjusted for age and year of diagnosis, by lymphoma subtype.
Cecilia Radkiewicz +9 more
wiley +1 more source
Differential diagnosis of ADHD with comorbid psychiatric and neurologic factors [PDF]
, 2000 M. Shichi
openalex +2 more sources
Collapsing high-end categories of comorbidity may yield misleading results
Clinical Epidemiology, 2009 Timothy L LashDepartment of Epidemiology, Boston University School of Public Health, Boston, MA, USA; Department of Clinical Epidemiology, Aarhus University Hospital, Aarhus, DenmarkAbstract: Adequate control of comorbidity has long been recognized as a ...
Timothy L Lash
doaj
Comorbidity of five chronic health conditions in elderly communityresidents: determinants and impact on mortality [PDF]
, 2000 Gerda G. Fillenbaum +4 more
openalex +1 more source
American Journal of Hematology, Volume 98, Issue 1, Page 180-192, January 2023., 2023 Abstract Direct comparisons of the effectiveness of the numerous novel therapies in the diffuse large B‐cell lymphoma (DLBCL) treatment landscape in a range of head‐to‐head randomized phase 3 trials would be time‐consuming and costly. Comparative effectiveness studies using real‐world data (RWD) represent a complementary approach.
Grzegorz Nowakowski +4 more
wiley +1 more source